Sally was awarded a BSc Hon Biochemistry degree from Leeds University in 1998 and in 2000 obtained a place on the NHS Clinical Scientist training programme in the North West of England. She obtained Fellowship of the Royal College of Pathologists in 2008 and shortly after this moved to London where she took on a Consultant Clinical Biochemist position at Barts Health NHS Trust. In 2014 Sally moved to her current position in Guildford. She leads a team of research scientists, focusing on analytical aspects and clinical applications of the Faecal Immunochemical Test (FIT) and other biomarkers, supporting early diagnosis of Colorectal Cancer. Sally was on the BSG / ACP guideline group representing biochemistry. She co-chairs the World Endoscopy Organisation expert working group on FIT for Screening and is Chair of an International Federation of Clinical Chemistry working group to standardise and harmonise FIT testing.
Clinical Advisory Board
Sally Benton
Consultant Clinical Biochemist and Clinical Lead for Clinical and Specialist Biochemistry Services at Berkshire and Surrey Pathology Services, a pathology network that serves 6 acute hospitals. Sally is also Director of the Bowel Cancer Screening South England Hub based at the Royal Surrey County Hospital, Guildford, serving a total population of about 16 million people across the South of England.
Read More
Prof Jon Emery
Herman Professor of Primary Care Cancer Research at the University of Melbourne, and the Victorian Comprehensive Cancer Centre (VCCC) Primary Care Research and Education Lead. He is a National Health and Medical Research Council (NHMRC) Leadership Fellow, and Director of the Cancer Australia Primary Care Collaborative Cancer Clinical Trials Group (PC4).
Read More
Following his medical training at Cambridge and Oxford, he has had a highly successful career in academic primary care.
His research focuses on the application of advances in genetic medicine, primary care oncology and the development and evaluation of complex interventions including computer decision support systems, and new cancer diagnostic and screening technologies. He is currently leading several trials on early detection of risk-based cancer in primary care.
Prof Finlay Macrae
Head of Colorectal Medicine and Genetics at The Royal Melbourne Hospital, he is a lead clinician in the Familial Cancer Clinic and is engaged in research into Colorectal Cancer genetics and new therapies for Inflammatory Bowel Disease (IBD).
He trained in London with the world's leading colonoscopist at the time (St Mark's Hospital) and brought this skill to Australia and his practice.
Read More
Prof Macrae, in 2016 was awarded an AO (Order of Australia) for his work in genetics and genomics. He is a Master of the World Gastroenterology Organization, and Fellow of the American Gastroenterology Association and Royal College of Physicians.
He initiated and is Chairman of The Australian and New Zealand Gastroenterology International Training Association (www.anzgita.org), with training programs throughout the Pacific Islands, Timor Leste and Nepal.
About us:
Contact
Rhythm Biosciences
Bio21 Institute
30 Flemington Road
Parkville VIC 3010
Australia
